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III. Abstract 
Sudden Infant Death Syndrome (SIDS) is a leading cause of infant mortality. Alterations 
in brainstem development of Serotonin (5HT) and γ-aminobutyric acid (GABA) are linked to its 
cause. The sympathetic premotor neurons located in the Nucleus of the Raphe Pallidus (NRP) in 
the brainstem have both 5-HT1A and GABA-A receptor subtypes that mediate protective 
cardiovascular responses to environmental stress. It is hypothesized that alteration in these 
receptors at the NRP will also modify protective thermoregulatory responses to hypoxic stress 
such as hypothermia. Using aseptic techniques, male and female Sprague-Dawley rats (230-
385g) were instrumented with radiotelemetry probes to non-invasively measure core temperature 
(Tc). Using a stereotaxic device, a steel cannula was also inserted into the brainstem, which 
allowed microinjection at the NRP. After recovery (1 week), rats were housed in a thermal 
gradient that allowed them to select their ambient temperature (STa) and thereby facilitated 
behavioral thermoregulation. Once acclimated to the gradient, 30 mM of either a 5-HT1A 
agonist (8OH-DPAT or “DPAT”), antagonist (WAY100635), a GABA-A agonist (Muscimol), 
antagonist (Bicuculine) or ACSF (control vehicle) was then microinjected into the NRP 
immediately before exposure to either 6% O2 (hypoxia) or 21% O2 (normoxia) for 60 min. In the 
normoxic control group, the typical short-term hyperthermic response to handling was abolished 
in rats injected with Muscimol but persisted in all other groups. Rats exposed to 6% O2 stress 
(hypoxia) demonstrated a typical hypothermic response. When the 5-HT1A receptor was 
activated by DPAT in hypoxic rats, this protective hypothermic response was significantly 
exacerbated compared to the control (ACSF). Similar responses resulted from injection of the 5-
HT1A antagonist (WAY). Modulation of the GABA-A receptor however had no effect versus 
ACSF injection.  Also in the hypoxic stress group, there were mild decreases in STa of ACSF 
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injected rats (4.3˚C) which was exacerbated in DPAT injected rats (8˚C). Rats injected with 
WAY seemed to reverse this trend initially with an increase in STa (3˚C) which quickly faded. 
Importantly, the STa responses to hypoxic stress helped facilitate Tc changes suggesting 
coordination between behavioral and autonomic thermoregulatory mechanisms that facilitated 
the protective hypothermic response. Previous data confirmed that GABA-A and 5-HT1A 
receptors in the NRP help mediate cardiovascular responses to stress. Although there was a 
sympatholytic effect from Muscimol injection in the normoxic group, the GABA-A receptors do 
not seem to facilitate thermoregulatory responses to hypoxic stress. This suggests that hypoxic 
stress is such a salient stimulus that it over rides the sympatholytic effect of GABA-A receptor 
activation or does so via alternative pathways. Hypoxic stress may instead mediate its 
hypothermic responses via the 5-HT1A receptor. When that receptor is activated by DPAT, there 
is an exacerbation of the hypothermic response to hypoxia. The behavioral thermoregulatory 
responses also facilitate the hypothermia in this group. The results from blockade of the 5-HT1A 
receptor with WAY are confounded by the short half-life of this receptor antagonist. Alterations 
in 5HT neuronal development in the brain stem may cause inadequate behavioral (STa decrease) 
and autonomic (Tc decrease) thermoregulatory responses to hypoxic stress. Understanding how 
dysfunction in brainstem 5HT leads to impairment in these protective responses to stress is 
essential in the diagnosis, and eventual prevention, of SIDS. 
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IV. Introduction 
Sudden Infant Death Syndrome (SIDS) is one of the leading causes of first-year infant 
mortality in the United States, killing 2,000 infants nationwide in 2010 alone (1). These 
seemingly healthy newborns are only diagnosed with SIDS posthumously, after passing away in 
their sleep without warning. When SIDS children are discovered deceased, they are usually 
found having been put to bed over swaddled (which likely leads to overheating) with blankets 
partially or fully covering their mouths (contributing to hypoxic stress). These repeated 
occurrences have revealed a strong link between infant SIDS mortality and this thermoregulatory 
stress from excessive insulation (2). The inability of these children to elicit essential 
thermoregulatory responses while resting in stressful environments (hypoxic conditions) 
indicates possible brainstem dysfunction that may contribute to their death.  
The brainstem is a grouping of neuronal connections responsible for the coordination and 
maintenance of critical bodily functions. These neurons manage the body’s autonomic responses 
to a wide variety of environmental stressors. When the brainstem cannot properly function, as in 
SIDS babies, these protective stress responses are impaired, and the health and survivability of 
the child is compromised. One such impairment includes the dysfunction of the brainstem’s 
ability to regulate core temperature (Tc) in response to a low-oxygen environment (hypoxia). 
Hypothermia has long been recognized for its protective effects in hypoxic conditions and has 
even been utilized therapeutically by inducing hypothermia in stroke patients to reduce cellular 
damage (3-6). This protective hypothermic response allows the body to slow metabolic rate and 
thereby reduce oxygen consumption, increasing organisms’ rate of survival (7). The etiology of 
SIDS has been proposed to involve the impairment of brainstem mediated neuronal responses to 
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stress. In particular, the failure of brainstem serotonin in mediating these otherwise protective 
thermoregulatory responses may increase the risk of SIDS (8).  
Brainstem neurotransmitters, such as serotonin (5 Hydroxytryptamine: 5-HT), serve a 
vital role in signaling autonomic protective responses, including modulating sympathetic 
responses to stress (9). Dysfunctional 5-HT in these regions may prevent adequate protective 
responses to environmental stressors. How brainstem 5-HT works to coordinate protective 
autonomic responses in hypoxic environments and what possible role this neurotransmitter may 
play in Sudden Infant Death Syndrome is of particular interest to this study. Previous studies 
have discovered an abnormal development of both 5-HT neurons and 5-HT receptors in areas of 
the brainstem, including the Nucleus Raphe Pallidus (NRP), in infants that die of SIDS (10). 
Specifically, the absence of, or reduction in, 5-HT1A receptors characterize the brainstems of 
SIDS afflicted infants. The overall purpose of this inhibitory receptor is unclear; however, many 
hypothesize its role in triggering protective cardiovascular, respiratory, and thermoregulatory 
responses to otherwise fatal stressors, including overheating, hypoxia, and hypercapnia (9,10). A 
normal child should be able to respond and survive exposure to these exogenous stressors; 
however, children with dysfunctional 5-HT1A receptors may be unable to elicit protective 
responses and therefore increase their risk of SIDS. This idea is supported by studies that have 
found 5-HT1A receptors in areas of the brainstem, including the NRP, that serve a role in 
cardiovascular protective responses (elevating heart rate and blood pressure) as well as protective 
respiratory responses (coughing and increased ventilation) in response to environmental stressors 
(9,11).  
Another brainstem inhibitory receptor known for its role in mediating stress responses is 
the γ-aminobutyric acid subtype A (GABA-A) receptor. GABA-A receptors in the NRP are 
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known to play a role in regulating sympathetic cardiovascular (heart rate) and thermoregulatory 
(core temperature) mechanisms (9,12). In SIDS infants, there is a significant reduction in 
GABA-A receptors in the same NRP region of the brainstem characterized by abnormal 5-HT1A 
receptor and receptor binding (13). These regions of parallel abnormalities in neurotransmitter 
receptors suggests that the interaction between 5-HT1A and GABA-A receptors may be the 
cause of SIDS infants’ homeostatic distress.  
This experiment aims to establish both the normoxic controls and hypoxic stress 
experiments investigating how both 5-HT1A and GABA-A receptors in the NRP of Sprague-
Dawley rats work to mediate thermoregulatory responses to hypoxic stress. GABA-A receptors 
generally inhibit neuronal firing, and are ubiquitous in the brainstem, so by activating these 
receptors in select serotonin-rich brainstem locales, the effect of those brainstem nuclei can be 
evaluated. When facing hypoxic conditions, organisms use a variety of methods to regulate their 
core body temperature, some even choosing colder ambient temperatures to facilitate protective 
hypothermia (14). By allowing rats to select their own ambient temperature (STa) in a low 
oxygen environment, this study can effectively measure the behavioral responses of rats to 
hypoxic stress. Additionally, physiologic responses to hypoxic stress can be measured by 
instrumenting these rats with probes that continuously monitor Tc and motor activity. With this 
capability to measure thermoregulation (both behaviorally and physiologically) in response to 
low oxygen, the specific roles of the 5-HT1A and GABA-A receptors can be determined through 
their pharmaceutical activation and deactivation. In conducting some of these experiments with 
normoxic controls, the specific effects of each pharmacological drug in an unstressed rat can be 
determined and later compared with thermoregulatory data from rats facing hypoxic stress. It is 
predicted that the hypothermic response to hypoxia will be altered by the pharmacologic 
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intervention of these two receptors in the NRP. Specifically, the activation of 5-HT1A and 
GABA-A receptors is predicted to alter the normal thermoregulatory response to hypoxic stress 
leading to a cooler STa and Tc. The deactivation of 5-HT1A and GABA-A receptors during 
hypoxic stress is predicted to alter the protective thermoregulatory response to hypoxic stress 
leading to the selection of a warmer STa and thus an increased Tc. This study looks to determine 
the role of 5-HT1A and GABA-A receptors in protective responses to hypoxic stress, 
investigating its ability to mediate protective thermoregulatory responses, and thereby discover 
what role these receptors may play in SIDS. 
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V. Methodology 
 Sprague-Dawley rats (male and female, 7 weeks, 230-385g) were first surgically 
instrumented with an abdominal radiotelemetry probe (DSI model TA-F40) and a steel brainstem 
cannula (26 mm, 20 gauge). The radiotelemetry probe allowed for continuous non-invasive 
measurements of core temperature and motor activity during experiments (Fig 1). The steel 
cannula was positioned using a stereotaxic device, granting microinjection access to the NRP  
(-2.3 mm rostral/caudal, -0.0 mm medial/lateral, and -9.2 mm dorsal/ventral from lambda 
coordinates; which places the cannula at the midline at the caudal end of the facial nucleus). Rats 
then recovered for at least 1 week or until they had sufficiently regained their pre-surgical 
weight. Rats then were placed in a thermogradient (Fig 2) and allowed to acclimate for at least 
six hours (usually overnight). The temperature gradient ranged in temperatures from 15±0.2 °C 
to 40 ± 0.2°C, allowing rats to select their preferred ambient temperature. Photosensors and 
temperature probes embedded throughout the gradient continuously monitored the rat’s location 
and behaviorally selected temperature (STa). Adequate food and water was available in the 
center of the gradient as well as at both ends limiting the rats preference for location based on 
consumption needs. 
 
Figure 1. Abdominal radio telemetry probe (DSI model TA-F40) that is surgically implanted 
into the rat’s peritoneal cavity to measure core temperature (Tc) and motor activity. 
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Figure 2. Schematic and image of temperature gradient that allows rats to behaviorally 
thermoregulate by selecting ambient temperature (STa) ranging from 15±0.2 °C to 40±0.2°C. 
“A” represents food distributed evenly across the gradient in three different locations. “B” 
represents water that was distributed at three evenly spaced locations along gradient.  
 
 Once acclimated, rats underwent six experiments involving the microinjection of drugs 
that modify neurotransmission or a control vehicle (artificial cerebral spinal fluid: ACSF, or 
sham: handling without volume injection) into the NRP (access through brainstem cannula) 
(Table 1). The sham control group allowed for evaluation of any handling effect on the rats 
during the microinjection process. The two control groups (ACSF and Sham) were combined 
into a single control group when differences found after four rats between sham and ACSF rats 
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were statistically insignificant. Experiments were limited to two a day and allowed for a two-
hour recovery period between the ending of one experiment and the start of the next. 
Experiments entailed microinjecting 0.3 µL of either 30 mM Muscimol, 30 mM Bicuculline 
methiodide, 30 mM 8-OH-DPAT (DPAT), 30 mM WAY100635 (WAY)) or sham/ACSF control 
vehicle, over 5 minutes using a Hamilton 5 µL syringe, followed by recording of subsequent 
thermoregulatory responses for 180 minutes at 21 % O2 (normoxia). The hypoxic stress 
experiments used 6 % O2 for 60 minutes followed by 120 minutes of recovery at normoxic 
conditions (Fig 3). Therefore, the timeline of experiments was identical in these control groups. 
Muscimol works as a GABA-A receptor agonist, which activated the inhibitory GABA-A 
receptors, suppressing the overall neural activity in the NRP. Bicuculine methiodide (Bicuculine) 
is a GABA-A receptor antagonist, which blocked the GABA receptors preventing the inhibition 
of the NRP. DPAT works as an agonist to the inhibitory 5-HT1A receptor, while WAY is a 5-
HT1A receptor antagonist blocking the activation of this receptor and thereby releasing its 
inhibition (Table 1). Once thermoregulatory responses were recorded, the rat was sacrificed and 
the affected microinjection region of the brain was immediately stained with a potassium 
permanganate injection into the brain cannula. The rat was then perfused with heparin-saline 
followed by 5% formalin, and the brain was harvested. The brain then incubated in 10% formalin 
for one week and then in a 30% sucrose solution for cryoprotection. Once the brain was ready, 
50-micron slices of the brainstem were produced using a cryostat. After slicing, brainstem slides 
were stained using cresyl violet and histological analysis confirmed the cannula positioning in 
the NRP of the brainstem. Rats determined to have a successful cannula positioning exhibited a 
potassium permanganate stain within  ± 1.5 mm of the caudal end of the facial nucleus (-2.3 mm 
from interaural line), within 0.75 mm of the midline, and within 1.0 mm of the ventral surface 
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(Fig 4). Rats confirmed to have cannulas in the NRP (histological hits) were included in data to 
be analyzed and later compared with data collected from hypoxic stress experiments. All 
statistical tests were run using a two-way ANOVA with a Tukey post hoc test over the 60-minute 
hypoxic or normoxic period following microinjection (α level = 0.05). 
 
Table 1. Experimental Design Chart  
NRP 
Microinjection  
Experiment Number  Goals/Experimental Questions 
 
ACSF § 
Exp 1A: Normal 21% O2 
(normoxia) 
Exp 1B: 6% O2 (hypoxia) 
Control vehicle injection: quantify normal 
handling in unstressed rat (1A) vs hypothermic 
response to 6% O2 (1B) 
Sham 
microinjection§ 
Exp 2A: Normal O2 
Exp 2B: 6% O2 (hypoxia) 
Zero volume injection: quantify normal handling 
(2A) vs hypothermic response to 6% O2 without 
volume expansion in brainstem (2B) 
Muscimol – 
activates GABA 
receptor* 
Exp 3A: Normal 21% O2 
(normoxia) 
Exp 3B: 6% O2 (hypoxia) 
Quantify any Tc and STa change when NRP is 
blocked in normoxic rat (3A).  
Does the NRP mediate hypothermic responses 
(decreased Tc and STa) to hypoxia (3B)? 
Bicuculine – 
blocks GABA 
receptor* 
Exp 4A: Normal 21% O2 
(normoxia) 
 
Exp 4B: 6% O2 (hypoxia) 
Quantify any Tc and STa change when NRP is 
uninhibited in normoxic rat (4A).  
Does removal of inhibition on NRP alter the 
hypothermic responses to hypoxia (4B)?  
8OH-DPAT –
activate 5-
HT1A receptor 
Exp 5A: Normal 21% O2 
(normoxia) 
 
Exp 5B: 6% O2 (hypoxia) 
Quantify any Tc and STa change when the 5-
HT1A receptor is activated in normoxic rat (5A)  
Does activation of the 5-HT1A receptor alter the 
hypothermic responses to hypoxia (5B)?  
WAY100635 - 
block 5-HT1A 
receptor 
Exp 6A: Normal 21% O2 
(normoxia) 
 
Exp 6B: 6% O2 (hypoxia) 
Quantify any Tc and STa change when the 5-
HT1A receptor is inhibited in normoxic rat (6A)  
Does inhibition of the 5-HT1A receptor alter 
hypothermic responses to hypoxia (6B)?  
§After four rats, the difference between ACSF and Sham groups were statistically insignificant, 
so the two groups were combined into one control group. *GABA is an inhibitory 
neurotransmitter therefore activation of this receptor will decrease overall neuronal function 
while inactivation of it will release that inhibition.  
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Figure 3. Experimental Protocol Timeline: After 6-hour acclimation period and stable Tc 
reached, drugs were microinjected that selectively alter either GABA-A or 5-HT1A receptor 
function. Immediately following, hypoxic/normoxic experiments were conducted which 
consisted of 60 minutes hypoxia (or 60 min of normoxia at 21% O2) followed by at least 120 
minutes of normoxic recovery. 
 
 
 
Figure 4. Microinjection site in the NRP of the brainstem. Top image shows a stained 
histological section with an arrow pointing at the injected potassium permanganate spot. The 
potassium permanganate stain is within the parameters of successful cannula placement. Bottom 
image shows an atlas drawing of the slice. 
Normoxic Experiments 
Acclimation to 
Gradient > 6 hrs 
21 % O2 (60 min) followed 
by Recovery (> 2 hrs) 
21 % O2 (60 min) followed by 
Recovery (> 2 hrs) 
Control 
period 
Control 
period 
microinjection microinjection 
Hypoxic Experiments 
Acclimation to 
Gradient > 6 hrs 
6 % O2 
60 min 
Recovery (> 2 hrs) 6 % O2 
60 min 
Recovery (> 2 hrs) Control 
period 
Control 
period 
microinjection microinjection 
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VI. Results 
 All rats placed in a normoxic environment (21 % O2) following microinjection exhibited 
an initial increase in core temperature, except for rats injected with GABA-A receptor agonist, 
Muscimol (Fig 5). Over the hour following microinjection, a two-way ANOVA with a Tukey 
post hoc test showed a statistically significant difference between the core temperatures of rats 
injected with Muscimol as compared to rats injected with ACSF (p < 0.001), DPAT (p < 0.001), 
or WAY (p = 0.029). Activation and inhibition of the 5-HT1A or GABA-A receptors in the NRP 
during normoxia, did not appear to cause significant behavioral responses to handling stress. 
However, due to the limited sample size of rats with selected ambient temperature data (ACSF 
control N = 1), statistical differences could not be concluded for the behavioral thermoregulatory 
changes in our normoxia study (Fig 6). 
 
Figure 5. Body core temperature (Tc) responses to microinjection of drug with 1 hour 21% O2 in 
rats. There was a hyperthermic response to handling in each group, except Muscimol, which 
abolished this effect. Statistically significant differences in rat Tc over the 21% O2 hour was 
found between Muscimol with ACSF, DPAT, and WAY. Error bars in supplemental figures. 
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Figure 6. Selected ambient temperature (STa) responses to microinjection followed by 1 hour 
21% O2 in rats. Limited sample sizes makes behavioral thermoregulatory changes difficult to 
conclude. Preliminary data does not appear to show any significant behavioral responses to 
handling stress when the 5HT1A or GABA-A receptor is modulated. Error bars included in 
supplemental figures section. 
 
All rats placed in a hypoxic environment (6% O2) following microinjection displayed a 
protective thermoregulatory response depicted by a decrease in core temperature (Fig 7). 
Modulation of the NRP GABA-A receptor during hypoxic stress did not show any significant 
differences in core temperature as compared to rats injected with the control vehicle. Activation 
of the 5-HT1A receptors in the NRP with DPAT injection significantly exacerbated the 
hypothermic response to hypoxic stress as compared to the control (p < 0.001). Inhibition of the 
5-HT1A receptor by WAY injections exhibited a delayed drop in core temperature, trending with 
the control rats until around 25 minutes post injection. The selected ambient temperature of the 
rats appeared to initially increase following Muscimol and WAY injection and initially decrease 
following DPAT and Bicuculine injection with hypoxic stress (Fig 8). From this preliminary 
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data, rats injected with Muscimol showed a significant difference in STa during hypoxia 
compared to rats injected with ACSF (p = 0.003), DPAT (p < 0.001), WAY (p = 0.011), or 
Bicuculine (p = 0.029). 
 
 
Figure 7. Body core temperature (Tc) responses to 1 hour 6% O2 Stress in Rats. The 
hypothermic response to hypoxic stress appears modified by microinjection of 
agonists/antagonists to the 5-HT1A receptor, but not the GABA-A receptor, located at the NRP 
in the brainstem. Note NRP modulation by WAY appears impeded by its short half-life of 33 
minutes (15). Statistically significant differences in rat core temperature over the hour of 6% O2 
was found between Muscimol vs. DPAT, Muscimol vs. WAY, Muscimol vs. Bicuculine, ACSF 
vs. DPAT, ACSF vs. WAY, Bicuculine vs. DPAT, and WAY vs. DPAT. Error bars included in 
supplemental figures section. 
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Figure 8. Selected ambient temperature (STa) responses to 1 hour 6% O2 stress in rats. 
Behavioral thermoregulatory changes, such as decreasing STa, facilitate Tc changes as part of 
the protective hypothermic response to hypoxia. These behavioral mechanisms also may be 
affected by modification of 5HT1A receptors located at the NRP in the brainstem. Statistically 
significant differences in rat selected ambient temperature over the hour of 6% O2 was found 
between Muscimol with DPAT, ACSF, Bicuculine, and WAY. Error bars included in 
supplemental figures section. 
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VII. Discussion 
In a low oxygen environment (hypoxic stress), hypothermia serves as a protective response to 
facilitate survival. By lowering body temperature, animals lower their metabolic rate and thus the 
consumption of their already limited oxygen supply. The importance of this life-saving 
hypothermic response is highlighted by the fact that all of our rats reduced their core temperature 
when exposed to hypoxic stress (Fig 7). We predicted these hypothermic responses were 
meditated by the 5-HT1A and GABA-A receptors of the NRP. We expected that the activation of 
these receptors would increase the hypothermic response by lowering Tc and STa. Consequently, 
the inhibition of these receptors were expected to diminish this response thus increasing the rat’s 
Tc and STa.  
As expected, rats injected with 5-HT1A receptor agonist, DPAT, were indeed found to 
exacerbate their hypothermic response to hypoxia. This can be seen in the significant decrease in 
core temperature of rats injected with DPAT as compared to ACSF over the 6 % O2 hour (Fig 7). 
Additionally, rats with activated 5-HT1A receptors preferentially selected colder STa with low 
oxygen stress (Fig 8). The STa responses to hypoxic stress helps facilitate Tc changes suggesting 
coordination between behavioral and autonomic thermoregulatory mechanisms in inducing this 
protective hypothermic response. Since activation of this serotonin receptor seems to induce 
hypothermia, inhibition of the receptor was expected to impair or reverse these trends. Rats 
injected with the 5-HT1A receptor antagonist WAY initially appear to mute the behavioral 
hypothermic response by selecting a warmer STa (Fig 8). Additionally, we do not see a 
significant initial drop in core temperature greater than our ACSF control for the first 25 minutes 
following 5-HT1A inhibition. However, about halfway through the hour of hypoxic stress, rats 
injected with WAY unexpectedly dropped both their Tc and STa. The half-life of WAY is only 
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33 minutes (15), so in stressed rats with a higher metabolism it is suspected that the drug wore 
off before a full attenuation of the hypothermic response could be evident. Although the short 
half-life of WAY confounds any definitive conclusions about the inhibition of the 5-HT1A 
receptor, what is interesting is the increased drop in Tc (~1.5ºC) after the effects of WAY wore 
off. We would have expected that the Tc of rats would trend with our ACSF control rats after the 
serotonin receptors inhibition wore off; however, an exacerbated hypothermic response is seen 
(Fig 7). It has been suggested that perhaps since hypoxia is such an important, life-threatening 
stimulus, the inhibition of these receptors may trigger an increase in receptor expression on the 
neuronal surface, which combats this inhibition. If this were true, perhaps after the effects of 
WAY wore off there were a greater number of 5-HT1A receptors on the surface of these NRP 
neurons leading to increased activation and a greater hypothermic response to hypoxia. Another 
possibility is that an additional pathway mediates this hypothermic response.  When the 5-HT1A 
receptor was turned off, the rats were able to initiate hypothermia by means of a different 
pathway or receptor. When WAY no longer blocked the 5-HT1A receptors (around 30 minutes), 
these receptors became active again and the hypothermic response was then amplified. It is 
reasonable to hypothesize that there may be multiple pathways to initiate this life-saving 
response since hypoxia is such a salient stimulus. 
We suspected that the inhibition of the GABA-A receptor would release any inhibition on the 
SNS premotor neurons at the NRP and thereby attenuate the hypothermic response. The Tc and 
STa of rats injected with antagonist Bicuculine, however, remained similar to our ACSF control 
during the hour of hypoxia. This may indicate that GABA-A receptor plays little to no role in the 
thermoregulatory response to hypoxic stress or that there are redundant neuronal pathways that 
are stimulated by hypoxic stress to assure this vital survival response. It was suspected that 
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activation of the NRP GABA-A receptors would further inhibit the SNS premotor neurons 
thereby exacerbating the hypothermic response. However, similar to the Bicuculine injections, 
the Muscimol injections showed minimal effects in decreasing Tc and STa greater than the 
ACSF control (Fig 7 and 8). These findings suggest that perhaps the GABA-A receptor is not 
involved in this hypothermic response to hypoxia, or that both Muscimol and hypoxic stress 
maximally stimulated the GABA-A receptor. Hypoxic stress is such a prominent stimulus that 
perhaps all GABA-A receptors were stimulated with hypoxia alone and thus the activation by an 
agonist was not able to induce a greater response. Additionally, if hypoxic stress was such a 
strong stimulus for the GABA-A receptors, the inhibition by our antagonist may have been 
overwhelmed, thus ineffective, from the low dosage of this drug. Future experiments should look 
to determine whether an increase dosage of Bicuculine is able to attenuate this hyperthermic 
response if indeed hypoxic stress maximally stimulates these receptors. 
In our normoxic studies, most of our rats exhibited a handling response following injection of 
drug revealed by an initial increase in Tc that lasted approximately 45 minutes (Fig 5). Handling 
rats for injections should stress the rats leading to a sympathetic nervous system (SNS) response 
that should increase Tc (9). Since the normoxic study rats were not placed in a hypoxic 
environment, there would be no reason for this SNS Tc increase to be inhibited. Interestingly 
however, there is an absence of this handling response in rats with activated GABA-A receptors, 
as seen by the significantly lower Tc as compared to all other rats following microinjection of 
Muscimol (Fig 5). Previous studies have found that that activation of the GABA-A receptor in 
the NRP have shown similar sympatholytic effects by inhibiting heart rate and blood pressure 
increases following stress (9). Although this sympatholytic effect by Muscimol injection was 
exhibited by all of our rats at 21% O2, it was not exhibited by those rats under hypoxic stress. 
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This further signifies the strength of hypoxic stress as a stimulus, since it seems to have 
superseded this sympatholytic effect from GABA-A receptor activation. Little can be concluded 
in regards to the normoxia STa data, due to the limiting sample sizes (Fig 6).  
Overall, these preliminary data suggests that the 5-HT1A receptor may be responsible for the 
protective hypothermic response to hypoxic stress. Additionally, in the absence of hypoxic 
stress, modulation of the 5-HT1A receptor at the NRP appears to have little to no effect on Tc or 
STa. GABA-A receptors at the NRP do seem to induce a sympatholytic effect when activated at 
21 % O2; however, this effect is muted under hypoxic stress. The GABA-A receptor modulation 
does not appear to have any significant effect on Tc or STa during hypoxia, though increase 
dosage of GABA-A drugs should be tested in the future to support this claim. Alterations in 5HT 
neuronal development in the brain stem may cause inadequate behavioral (STa decrease) and 
autonomic (Tc decrease) thermoregulatory responses to hypoxic stress. Better understanding 
how dysfunction in brainstem 5HT leads to the impairment in these protective responses to stress 
is essential in the diagnosis, and eventual prevention, of SIDS. 
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VIII. Supplemental Figures 
 
 
Figure 9. Body core temperature (Tc) responses to microinjection of drug with 1 hour 21% O2 in 
rats. Error bars showing standard error of the mean for ACSF, DPAT, and WAY drug included. 
 
Figure 10. Body core temperature (Tc) responses to microinjection of drug with 1 hour 21% O2 
in rats. Error bars showing standard error of the mean for ACSF, Muscimol, and Bicuculine drug 
included. Statistically significant differences in rat Tc over the 21% O2 hour was found between 
Muscimol and ACSF. 
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Figure 11. Selected ambient temperature (STa) responses to microinjection of drug with 1 hour 
21% O2 in rats. Error bars showing standard error of the mean for DPAT and WAY drug 
included. 
 
 
Figure 12. Selected ambient temperature (STa) responses to microinjection of drug with 1 hour 
21% O2 in rats. Error bars showing standard error of the mean for Muscimol and Bicuculine drug 
included. 
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Figure 13. Body core temperature (Tc) responses to microinjection of drug with 1 hour 6% O2 in 
rats. Error bars showing standard error of the mean for ACSF, DPAT, and WAY drug included. 
Statistically significant differences in rat Tc over the 6% O2 hour was found between ACSF vs. 
DPAT and ACSF vs. WAY. 
 
Figure 14. Body core temperature (Tc) responses to microinjection of drug with 1 hour 6% O2 in 
rats. Error bars showing standard error of the mean for ACSF, Muscimol, and WAY drug 
included. Statistically significant differences in rat Tc over the 6% O2 hour was found between 
Muscimol vs. Bicuculine. 
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Figure 15. Selected ambient temperature (STa) responses to microinjection of drug with 1 hour 
6% O2 in rats. Error bars showing standard error of the mean for ACSF, DPAT, and WAY drug 
included. 
 
Figure 16. Selected ambient temperature (STa) responses to microinjection of drug with 1 hour 
6% O2 in rats. Error bars showing standard error of the mean for ACSF, Muscimol, and 
Bicuculine drug included. Statistically significant differences in rat selected ambient temperature 
over the hour of 6% O2 was found between Muscimol with ACSF and Bicuculine. 
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